Biotech company receives follow-on funding to accelerate ongoing clinical development efforts
COLUMBIA, Md. (May 8, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent Seed Funds investment of $200,000 into Rise Therapeutics, a Maryland-based biotechnology company. TEDCO’s Seed Funds invest in early-stage, technology and life sciences companies and provides access to gap financing.
"We are thrilled to receive this follow-on investment from TEDCO," said Gary Fanger, Ph.D, president and CEO of Rise Therapeutics. "This funding will allow us to accelerate our ongoing clinical development efforts and move closer to bringing our synthetic biology-based immunotherapy drugs to market; we are grateful to TEDCO for their support."